Skip to content
HowShorted

Akoustis Technologies, Inc. short interest in 2021

In 2021, Akoustis Technologies, Inc.'s disclosed short interest ran from 20.24% of shares outstanding on 15 Jan 2021 to 8.30% on 31 Dec 2021, a change of -11.94 percentage points. The year's high was 20.24% on 15 Jan 2021 and its low 7.55% on 30 Nov 2021, averaging 9.66% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.06 days on 13 Aug 2021. Full history: Akoustis Technologies, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Akoustis Technologies, Inc. in 2021

2021 in figures

Start of year
20.24% (15 Jan 2021)
End of year
8.30% (31 Dec 2021)
Change
-11.94 pp
High
20.24% (15 Jan 2021)
Low
7.55% (30 Nov 2021)
Average
9.66%
Highest days to cover
17.06 (13 Aug 2021)
SEC filings marked
6

Every report in 2021

Akoustis Technologies, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202120.24%12.19
29 Jan 202113.99%6.46
12 Feb 202111.11%4.0210-Q filed, results (8-K)
26 Feb 20218.95%5.26
15 Mar 20218.54%3.79
31 Mar 20219.50%6.02
15 Apr 20219.45%8.08
30 Apr 20217.82%8.69
14 May 20218.49%5.8610-Q filed
28 May 20218.61%12.60
15 Jun 20218.68%7.88
30 Jun 20219.77%7.74
15 Jul 20219.67%12.53
30 Jul 202110.36%15.15
13 Aug 20219.79%17.06
31 Aug 20219.60%8.1710-K filed
15 Sep 20219.63%10.93
30 Sep 20219.61%12.95
15 Oct 20218.51%8.73
29 Oct 20218.33%7.55results (8-K)
15 Nov 20217.74%7.4810-Q filed
30 Nov 20217.55%6.05
15 Dec 20217.69%5.93
31 Dec 20218.30%6.19

See also: Akoustis Technologies, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.